🇺🇸 FDA
Pipeline program

Anti-BCMA CAR-T cells

anti-BCMA CART

Phase 1 mab active

Quick answer

Anti-BCMA CAR-T cells for Multiple Myeloma is a Phase 1 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Multiple Myeloma
Phase
Phase 1
Modality
mab
Status
active

Clinical trials